These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Improvement of tardive dyskinesia with high doses of propranolol]. Moreira MJ; Karniol IG Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299 [No Abstract] [Full Text] [Related]
5. Treatment of tardive dyskinesia with propranolol. Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534 [TBL] [Abstract][Full Text] [Related]
6. Low-dose propranolol in tardive dyskinesia. Bacher NM; Lewis HA Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439 [No Abstract] [Full Text] [Related]
7. Propranolol, anxiety, and tardive dyskinesia. Bacher NA; Lewis HA J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849 [No Abstract] [Full Text] [Related]
8. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics. Kulik FA; Wilbur R Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690 [No Abstract] [Full Text] [Related]
9. Propranolol in the treatment of tardive dyskinesia. Perényi A; Farkas A Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627 [No Abstract] [Full Text] [Related]
10. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
11. [Tardive dyskinesia: etiology, clinical features and therapy]. Furer V; Lichtenberg P; Heresco-Levy U Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354 [No Abstract] [Full Text] [Related]
12. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Glazer WM J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326 [TBL] [Abstract][Full Text] [Related]